SNIC
SUPR
SNIC SUPR
Genome-wide study of mRNA degradation intermediates
Dnr:

SNIC 2018/8-292

Type:

SNAC Small

Principal Investigator:

Vicente Pelechano Garcia

Affiliation:

Karolinska Institutet

Start Date:

2018-09-27

End Date:

2019-10-01

Primary Classification:

30108: Cell and Molecular Biology

Allocation

Abstract

mRNAs present in the cell need to be translated to produce functional proteins. mRNA translation is a highly regulated process with multiple layers of control. Although translation initiation has been considered the rate-limiting step, and thus has been more intensively studied, recent evidence suggests that translation elongation is also highly regulated. Our lab has previously developed a method termed 5PSeq that takes advantage of the mRNA co-translational 5’-3’degradation to produce an in vivo ribosomal footprint. This approach, by sequencing the ends of 5’phosphorylated mRNA degradation intermediates, obtains a genome-wide drug-free measurement of ribosome dynamics. We will use this approach to investigate the translation bases of the non-genetic heterogeneity driving divergent gene expression responses within a clonal population using S. cerevisiae and human cell lines.